Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Originally approved by the FDA to manage type 2 diabetes, semaglutide gained widespread attention when clinical trials showed extraordinary results for weight loss leading to FDA approval specifically for chronic weight management under the brand name Wegovy
In a direct obesity trial, tirzepatide produced greater average weight loss, but both commonly caused gastrointestinal side effects
The semaglutide side effects users reported most often in clinical trials were: Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue More than 20% of trial participants reported these side effects, with 44% reporting nausea and 30% reporting diarrhea compared to 24% or fewer for vomiting, constipation, and abdominal pain
Ten units on your syringe always equals 0.1 mL of liquid
Genetics: Some genetic factors can affect how medication is absorbed and processed within your body
His expertise proved invaluable
US$ 24.53
US$ 26.95
US$ 20.82
US$ 23.91
US$ 28.59
US$ 21.17
